• 1
    Chew DJ. Diagnosing Initial and Recurrent Urinary Tract Infections in Dogs. Orlando, FL: North American Veterinary Conference; 2001.
  • 2
    Drekonja DM, Johnson JR. Urinary tract infections. Prim Care 2008;35:345367.
  • 3
    Fang LS, Tolkoff-Rubin NE, Rubin RH. Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technique. N Engl J Med 1978;298:413416.
  • 4
    Nicolle LE. Urinary tract infection: Traditional pharmacologic therapies. Dis Mon 2003;49:111128.
  • 5
    Moura A, Nicolau A, Hooton T, et al. Antibiotherapy and pathogenesis of uncomplicated UTI: Difficult relationships. J Appl Microbiol 2009;106:17791791.
  • 6
    Hooton TM, Winter C, Tiu F, et al. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA 1995;273:4145.
  • 7
    McCarty JM, Richard G, Huck W, et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med 1999;106:292299.
  • 8
    Iravani A, Tice AD, McCarty J, et al. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected]. Arch Intern Med 1995;155:485494.
  • 9
    Greenberg RN, Reilly PM, Luppen KL, et al. Randomized study of single-dose, three-day, and seven-day treatment of cystitis in women. J Infect Dis 1986;153:277282.
  • 10
    Katchman EA, Milo G, Paul M, et al. Three-day vs longer duration of antibiotic treatment for cystitis in women: Systematic review and meta-analysis. Am J Med 2005;118:11961207.
  • 11
    Fang LS, Tolkoff-Rubin NE, Rubin RH. Clinical management of urinary tract infection. Pharmacotherapy 1982;2:9199.
  • 12
    Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745758.
  • 13
    Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993;329:13281334.
  • 14
    Czaja CA, Hooton TM. Update on acute uncomplicated urinary tract infection in women. Postgrad Med 2006;119:3945.
  • 15
    Bartges J. Bacterial urinary tract infections: Simple and complicated. Vet Med 2005;100:224229.
  • 16
    Weese JS, Blondeau JM, Boothe DM, et al. Antimicrobial use guidelines for treatment of urinary tract disease in dogs and cats: Antimicrobial guidelines working group of the international society for companion animal infectious diseases. Vet Med Int 2011;2011:19.
  • 17
    Noli C, Koeman JP, Willemse T. A retrospective evaluation of adverse reactions to trimethoprim-sulphonamide combinations in dogs and cats. Vet Q 1995;17:123128.
  • 18
    Trepanier LA, Danhof RS, Toll J, et al. Clinical findings in 40 dogs with hypersensitivity associated with administration of potentiated sulfonamides. J Vet Intern Med 2003;17:647652.
  • 19
    Cribb AE, Lee BL, Trepanier LA, et al. Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: Clinical syndromes and pathogenesis. Adverse Drug React Toxicol Rev 1996;15:950.
  • 20
    Giger U, Werner LL, Millichamp NJ, et al. Sulfadiazine-induced allergy in six Doberman Pinschers. J Am Vet Med Assoc 1985;186:479484.
  • 21
    Hooton TM. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am 2003;17:303332.
  • 22
    Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643654.
  • 23
    Carter JM, Klausner JS, Osborne CA, et al. Comparison of collection techniques for quantitative urine culture in dogs. J Am Vet Med Assoc 1978;173:296298.
  • 24
    Comer KM, Ling GV. Results of urinalysis and bacterial culture of canine urine obtained by antepubic cystocentesis, catheterization, and the midstream voided methods. J Am Vet Med Assoc 1981;179:891895.
  • 25
    Pezzlo M, Mary KC, Deirdre LC. Chapter 3.12 Urine cultures. In: Isenberg HD, ed. Clinical Microbiology Procedures Handbook, 3rd ed. Washington, DC: ASM Press; 2010: 3.12.1-3.12-19.
  • 26
    Sanderson SL. Urinary system introduction. In: Kahn C, ed. The Merck Veterinary Manual, 10th ed. Whitehouse Station, NJ: Merck & Co.; 2010:1380.
  • 27
    Stamm WE, Wagner KF, Amsel R, et al. Causes of the acute urethral syndrome in women. N Engl J Med 1980;303:409415.
  • 28
    Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. In: CLSI document VET01-S2. Wayne, PA: CLSI; 2013.
  • 29
    Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. In: CLSI document M100-23. Wayne, PA: CLSI; 2013.
  • 30
    Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. In: CLSI document VET01-A4. Wayne, PA: CLSI; 2013.
  • 31
    Lavergne SN, Danhof RS, Volkman EM, et al. Association of drug-serum protein adducts and anti-drug antibodies in dogs with sulfonamide hypersensitivity: A naturally occurring model of idiosyncratic drug toxicity. Clin Exp Allergy 2006;36:907915.
  • 32
    Gruchalla RS, Sullivan TJ. Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine. J Allergy Clin Immunol 1991;88:784792.
  • 33
    Crowther J. The ELISA guidebook. In: JM W, ed. Methods in Molecular Biology. Totowa, NJ: Humana Press; 2001:347394.
  • 34
    Abouraya M, Sacco JC, Kahl BS, et al. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis. Br J Pharmacol 2011;71:566574.
  • 35
    Farrell J, Naisbitt D, Drummond N, et al. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animal and humans. Pharmacol Exp Ther 2003;306:229237.
  • 36
    Passmore CA, Sherington J, Stegemann MR. Efficacy and safety of cefovecin (Convenia) for the treatment of urinary tract infections in dogs. J Small Anim Pract 2007;48:139144.
  • 37
    Rogers KS, Lees GE, Simpson RB. Effects of single-dose and three-day trimethoprim-sulfadiazine and amikacin treatment of induced Escherichia coli urinary tract infections in dogs. Am J Vet Res 1988;49:345349.
  • 38
    Westropp JL, Sykes JE, Irom S, et al. Evaluation of the efficacy and safety of high dose short duration enrofloxacin treatment regimen for uncomplicated urinary tract infections in dogs. J Vet Intern Med 2012;26:506512.
  • 39
    Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 2012;366:10281037.
  • 40
    Gossius G, Vorland L. A randomised comparison of single-dose vs. three-day and ten-day therapy with trimethoprim-sulfamethoxazole for acute cystitis in women. Scand J Infect Dis 1984;16:373379.
  • 41
    Trienekens TA, Stobberingh EE, Winkens RA, et al. Different lengths of treatment with co-trimoxazole for acute uncomplicated urinary tract infections in women. BMJ 1989;299:13191322.